Survival benefit of nephrologic care in patients with diabetes mellitus and chronic kidney disease

Archives of Internal Medicine
Chin-Lin TsengLeonard Pogach

Abstract

The association of nephrologic care and survival in patients with diabetes mellitus and chronic kidney disease is unknown. Using data from 1997 to 2000, we conducted a retrospective cohort study of Veterans Health Administration clinic users having diabetes mellitus and stage 3 or 4 chronic kidney disease. The baseline period was 12 months and median follow-up was 19.3 months. Degree of consistency of visits to a nephrologist, defined as the number of calendar quarters in which there was 1 visit or more (range, 0-4 quarters), and covariates were calculated from the baseline period. The outcome measure was dialysis-free death. Of 39,031 patients, 70.0%, 22.4%, and 7.6% had early stage 3, late stage 3, and stage 4 chronic kidney disease, respectively, and 3.1%, 9.5%, and 28.2%, respectively, visited a nephrologist. Dialysis-free mortality rates were 9.6, 14.1, and 19.4, respectively, per 100 person-years. More calendar quarters with visits to a nephrologist were associated with lower mortality: adjusted hazard ratios were 0.80 (95% confidence interval, 0.67-0.97), 0.68 (95% confidence interval, 0.55-0.86), and 0.45 (95% confidence interval, 0.32-0.63), respectively, when the groups having 2, 3, and 4 visits were compared with tho...Continue Reading

Citations

Aug 15, 2014·PloS One·Michael E MathenyEdward D Siew
Oct 23, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Roberto MinutoloUNKNOWN REport of COmorbidities in non-Dialysis Renal Disease Population in Italy (RECORD-IT) Study Group
Dec 3, 2014·Primary Care·Samuel Snyder, Jones Sam John
Oct 6, 2010·Journal of General Internal Medicine·Adrienne S AllenThomas D Sequist
Oct 16, 2010·Journal of the American Society of Nephrology : JASN·Ziyad Al-AlySeth Eisen
Aug 6, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Luca De NicolaUNKNOWN SIN-TABLE CKD Study Group
Mar 16, 2013·Clinical Journal of the American Society of Nephrology : CJASN·Guofen YanKeith C Norris
Mar 7, 2012·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Mangala RajanAnushua Sinha
Dec 22, 2009·Clinical and Experimental Nephrology·Benjamin D MorrowCasey L Cotant
Jul 7, 2009·International Urology and Nephrology·Ai-Hua ZhangDimitrios G Oreopoulos
Jun 6, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·I-Wen WuMai-Szu Wu
Jan 8, 2010·The New England Journal of Medicine·Hanna Abboud, William L Henrich
Oct 17, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Ian Wu, Chirag R Parikh
Jan 8, 2013·The Medical Clinics of North America·Brendan T BowmanW Kline Bolton
May 25, 2012·Kidney International·Luca De NicolaUNKNOWN Italian Society of Nephrology Study Group Target Blood pressure Levels (TABLE) in CKD
Nov 12, 2009·Kidney International·Lesley A Stevens, Andrew S Levey
Aug 3, 2012·Kidney International·Ziyad Al-AlyAnn M O'Hare
Jul 4, 2015·Journal of General Internal Medicine·Ana C RicardoUNKNOWN CRIC Study Investigators
Apr 13, 2010·Lancet·Matthew T JamesMarcello Tonelli
Jan 26, 2016·The Journal of Urology·Maria C MirDipen J Parekh
Feb 22, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Georges SaabUNKNOWN KEEP Investigators
Aug 7, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Bertram Kasiske, Kai-Uwe Eckardt
Nov 13, 2010·International Journal of Clinical Practice·S Herget-RosenthalA Kribben
Nov 21, 2015·Journal of Nephrology·Mario PacilioLuca De Nicola
Oct 9, 2015·Canadian Journal of Kidney Health and Disease·Samuel A SilverRon Wald
Sep 1, 2015·The Medical Clinics of North America·Meghan M Kiefer, Michael J Ryan
Oct 16, 2015·PloS One·Silvio BorrelliGiuseppe Conte
Feb 18, 2017·PloS One·Luca De NicolaRoberto Minutolo
Feb 18, 2017·Journal of Clinical Medicine·Jeremy D Young, Melissa E Badowski
Mar 7, 2017·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Ju-Yeh YangKuan-Yu Hung
Jan 7, 2009·Therapeutic Advances in Cardiovascular Disease·Anita M Saran, Thomas D DuBose
Jun 30, 2011·Nature Reviews. Nephrology·Adeera Levin, Paul E Stevens
Oct 23, 2008·Current Opinion in Nephrology and Hypertension·Raymond M Hakim
Oct 10, 2015·Clinical Journal of the American Society of Nephrology : CJASN·Guofen YanKeith C Norris
Dec 14, 2011·Journal of the American Society of Nephrology : JASN·Edward D SiewMichael E Matheny
Aug 1, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Michal L MelamedThomas H Hostetter
Dec 12, 2012·American Journal of Nephrology·Michael J FischerKevin T Stroupe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

© 2021 Meta ULC. All rights reserved